You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Expert Perspectives on Raising the Bar in Epilepsy: Treatment Selection, Dosing Considerations, and Interactions

  • Authors: Gregory Krauss, MD; Steve Chung, MD; Michael D. Privitera, MD
  • CME / CE Released: 4/6/2022
  • Valid for credit through: 4/6/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for neurologists, primary care physicians, orthopedists, orthopedic surgeons, and nurses.

The goal of this activity is that learners will be better able to use strategies to improve the likelihood of seizure freedom in their patients with epilepsy, and understand how to make dosing changes to reduce the risk of adverse events when multiple antiseizure medications (ASMs) are used.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Potential consequences of poorly controlled seizures in patients with focal epilepsy
    • Clinical data of seizure freedom rates for currently approved ASMs
    • How to titrate the dose of a new ASM to reduce the occurrence of adverse events


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Gregory Krauss, MD

    Professor of Neurology
    Department of Neurology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland

    Disclosures

    Participation by Dr Krauss does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

    Consultant or advisor for: SK Life Science
    Research funding from: Cerevel; EpiWatch, Inc.
    Contracted researcher for: Cerevel
    Owns stock (privately owned) in: EpiWatch, Inc. 

  • Steve Chung, MD

    Professor of Neurology
    University of Arizona School of Medicine
    Phoenix, Arizona

    Disclosures

    Consultant or advisor for: SK Life Science; Sunovion; UCB
    Speaker or member of speakers bureau for: Eisai; GW Pharma; SK Life Science; Sunovion; UCB
    Research funding from: SK Life Science

  • Michael D. Privitera, MD

    Professor of Neurology
    University of Cincinnati and Gardner Neuroscience Institute
    Cincinnati, Ohio

    Disclosures

    Consultant or advisor for: SK Life Science
    Speaker or member of speakers bureau for: Greenwich/Jazz Pharmaceuticals; Neurelis; SK Life Science
    Research funding from: Neurelis

Editor

  • Christina T. Loguidice, BA

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Christina T. Loguidice, BA, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Expert Perspectives on Raising the Bar in Epilepsy: Treatment Selection, Dosing Considerations, and Interactions

Authors: Gregory Krauss, MD; Steve Chung, MD; Michael D. Privitera, MDFaculty and Disclosures

CME / CE Released: 4/6/2022

Valid for credit through: 4/6/2023

processing....

Educational Impact Challenge

The goal of this activity is that learners will be better able to use strategies to improve the likelihood of seizure freedom in their patients with epilepsy, and understand how to make dosing changes to reduce the risk of adverse events when multiple antiseizure medications (ASMs) are used.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print